Expertise at every step
State-of-the-art technology
Cutting-edge science
End-to-end services
State-of-the-art technology
Cutting-edge science
End-to-end services
State-of-the-art technology
Cutting-edge science
End-to-end services
We are a US-based, world-class CDMO driven by the belief that scientific expertise and manufacturing excellence combined can bring life-altering therapies to patients faster. Our team of industry-leading experts supports a diverse range of projects with broad experience and constant innovation. Our comprehensive portfolio of capabilities from lab-scale development through commercial manufacturing ensures quality, scalability, and speed for cutting-edge therapeutics from a single source at every stage.
We have invested in state-of-the-art facilities and equipment to ensure delivery of the highest quality sterile injectable products. Our team focuses on building collaborative relationships with our clients, while leveraging our subject matter expertise to deliver a seamless experience from process development through distribution.
On-site development and testing laboratories led by highly experienced scientists
Advanced characterization and leading-edge technology
Advanced sterile filling systems to support diverse container types and batch sizes
Join our team and contribute toward providing high quality pharmaceutical development and manufacturing solutions to our clients.
With state-of-the-art facilities and equipment, and a team of technical experts, we are focused on making a difference for our clients and the patients who benefit from the novel therapeutics we deliver.
If you thrive in a fast-paced, growth-driven environment where your contributions can make a direct impact, we would love to hear from you.
Meet us at an upcoming event
Boston, MA | June 16-19, 2025
New Brunswick, NJ | September 18-19, 2025
Frankfurt, Germany | October 28-30, 2025
New York City, NY | March 23- 26, 2026
Philadelphia, PA | June 2-4, 2026
San Diego, CA | June 22-25, 2026
Exploring innovations, challenges, and future horizons in parenteral drug delivery.
For this roundtable, Contract Pharma called upon thought leaders across the pharmaceutical services sector to address “3 Key Trends” impacting the CDMO industry in 2025 and beyond.
Bringing a sterile injectable product from development to commercialization requires a seamless scale-up process—one that minimizes risk, optimizes efficiency, and ensures regulatory success. In this exclusive webinar, experts from August Bioservices will discuss the critical factors that make or break a successful scale-up, sharing insights from a CDMO’s unique perspective.